- China
- /
- Medical Equipment
- /
- SZSE:301367
Global Growth Stocks With High Insider Ownership To Watch
Reviewed by Simply Wall St
As global markets navigate a landscape of steady interest rates and mixed economic signals, investors are keenly observing sectors where value has been outperforming growth. In this context, companies with high insider ownership can be particularly appealing, as such ownership often indicates confidence in the company's long-term potential and alignment with shareholder interests.
Top 10 Growth Companies With High Insider Ownership Globally
Name | Insider Ownership | Earnings Growth |
Zhejiang Jolly PharmaceuticalLTD (SZSE:300181) | 23.3% | 26% |
Pharma Mar (BME:PHM) | 11.8% | 40.8% |
Laopu Gold (SEHK:6181) | 36.4% | 47.2% |
Vow (OB:VOW) | 13.1% | 111.2% |
CD Projekt (WSE:CDR) | 29.7% | 39.1% |
Global Tax Free (KOSDAQ:A204620) | 21.8% | 89.3% |
Elliptic Laboratories (OB:ELABS) | 22.6% | 88.2% |
Nordic Halibut (OB:NOHAL) | 29.8% | 56.3% |
Ascentage Pharma Group International (SEHK:6855) | 17.9% | 60.9% |
Synspective (TSE:290A) | 13.2% | 37.4% |
Here we highlight a subset of our preferred stocks from the screener.
América Móvil. de (BMV:AMX B)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: América Móvil, S.A.B. de C.V. is a telecommunications company offering services across Latin America and internationally, with a market cap of MX$871.91 billion.
Operations: The company generates revenue from its Cellular Services segment, amounting to MX$869.22 billion.
Insider Ownership: 22.7%
Earnings Growth Forecast: 25.3% p.a.
América Móvil shows potential as a growth company with high insider ownership, trading 49.1% below fair value and expected to see significant annual earnings growth of 25.3%, outpacing the MX market. However, revenue growth lags behind the market at 5% annually, and profit margins have declined from last year. Despite a recent dividend increase announcement, net income has decreased substantially year-over-year, highlighting financial challenges amidst its high debt levels.
- Click here and access our complete growth analysis report to understand the dynamics of América Móvil. de.
- Our valuation report unveils the possibility América Móvil. de's shares may be trading at a discount.
BMC Medical (SZSE:301367)
Simply Wall St Growth Rating: ★★★★★☆
Overview: BMC Medical Co., Ltd. focuses on researching, developing, manufacturing, and supplying medical equipment and consumables for respiratory health in China with a market cap of CN¥5.76 billion.
Operations: The company generates revenue primarily from its Surgical & Medical Equipment segment, amounting to CN¥779.20 million.
Insider Ownership: 31.7%
Earnings Growth Forecast: 31.3% p.a.
BMC Medical is positioned for growth, with revenue expected to increase by 22.5% annually, surpassing the CN market's growth rate. The company's earnings are forecasted to grow significantly at 31.3% per year, also outpacing the market average. Despite trading at 46.1% below its estimated fair value and having no recent insider trading activity, BMC faces challenges with declining profit margins and an unstable dividend track record.
- Click here to discover the nuances of BMC Medical with our detailed analytical future growth report.
- The analysis detailed in our BMC Medical valuation report hints at an deflated share price compared to its estimated value.
Gudeng Precision Industrial (TPEX:3680)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Gudeng Precision Industrial Co., Ltd. offers technology services on a global scale and has a market cap of NT$40.78 billion.
Operations: Gudeng Precision Industrial Co., Ltd. generates its revenue from technology services provided globally.
Insider Ownership: 30.8%
Earnings Growth Forecast: 28.9% p.a.
Gudeng Precision Industrial demonstrates strong growth potential, with revenue projected to rise by 25.4% annually, exceeding the TW market's rate. Earnings are also expected to grow significantly at 28.9% per year. Recent financial results show an increase in sales to TWD 6.54 billion and net income of TWD 1.17 billion for 2024, highlighting robust performance despite a highly volatile share price and low forecasted return on equity of 17.7%.
- Click to explore a detailed breakdown of our findings in Gudeng Precision Industrial's earnings growth report.
- Upon reviewing our latest valuation report, Gudeng Precision Industrial's share price might be too optimistic.
Turning Ideas Into Actions
- Get an in-depth perspective on all 897 Fast Growing Global Companies With High Insider Ownership by using our screener here.
- Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
- Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.
Want To Explore Some Alternatives?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
If you're looking to trade BMC Medical, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.
With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.
Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.
Sponsored ContentValuation is complex, but we're here to simplify it.
Discover if BMC Medical might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About SZSE:301367
BMC Medical
Researches, develops, manufactures, and supplies medical equipment and consumable in the field of respiratory health in China.
Flawless balance sheet with high growth potential.
Similar Companies
Market Insights
Community Narratives

